Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperaldosteronism
ADR ID BADD_A07297
ADR Hierarchy
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.01      Adrenal cortical hyperfunctions
05.01.01.006      Hyperaldosteronism
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.04      Sodium imbalance
14.05.04.006      Hyperaldosteronism
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.04      Endocrine and metabolic secondary hypertension
24.08.04.005      Hyperaldosteronism
Description A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. | Primary hyperaldosteronism caused by the excess production of ALDOSTERONE by an ADENOMA of the ZONA GLOMERULOSA or CONN ADENOMA. [MeSH]
MedDRA Code 10020571
MeSH ID D006929
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Aldosteronism | Aldosteronism NOS | Hyperaldosteronism | Hyperaldosteronemia | Hyperaldosteronaemia | Conn Syndrome | Syndrome, Conn | Primary Hyperaldosteronism | Hyperaldosteronism, Primary | Conn's Syndrome | Conns Syndrome | Syndrome, Conn's
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000334%
BADD_D00551Cyclosporine0.000111%
BADD_D00979Furosemide0.000021%
BADD_D01668Pantoprazole0.000025%
BADD_D02247Topiramate0.000176%
The 1th Page    1    Total 1 Pages